Search Results - "TREFIGLIO, Roberta"

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial by Madruga, José Valdez, Dr, Cahn, Pedro, MD, Grinsztejn, Beatriz, MD, Haubrich, Richard, Prof, Lalezari, Jacob, MD, Mills, Anthony, MD, Pialoux, Gilles, Prof, Wilkin, Timothy, MD, Peeters, Monika, MSc, Vingerhoets, Johan, PhD, de Smedt, Goedele, MD, Leopold, Lorant, MD, Trefiglio, Roberta, PharmD, Woodfall, Brian, MD

“…Summary Background Antiretroviral agents active against drug-resistant HIV-1 are needed for treatment-experienced patients. The aim of this trial was to assess…”
Get full text

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study by Pimenta, M Cristina, Torres, Thiago Silva, Hoagland, Brenda, Cohen, Mirian, Mann, Claudio Gruber, Jalil, Cristina M, Carvalheira, Eduardo, Freitas, Lucilene, Fernandes, Nilo, Castanheira, Debora, Benedetti, Marcos, Moreira, Julio, Simpson, Keila, Trefiglio, Roberta, O'Malley, Gabrielle, Veloso, Valdilea G, Grinsztejn, Beatriz

“…Although long-acting, injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) has proven efficacious for HIV prevention in clinical trials, research…”
Get full text

Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter study by Torres, Thiago S, Teixeira, Sylvia L M, Hoagland, Brenda, Konda, Kelika A, Derrico, Monica, Moreira, Ronaldo I, Guanira, Juan V, Benedetti, Marcos, Nazer, Sandro, Calvo, Gino M, Vargas, Silver, Benites, Carlos, Bigolin, Álisson, Alonso Neto, José Boullosa, Farias, Alessandro, Guimarães Lacerda, Marcos Vinícius, Raenck Silva, Daila Alena, Paz, Leidijany Costa, Madruga, José Valdez, Salvatierra Flores, Hector Javier, Boluarte, Ginjaylan Prada, Osco Tamayo, Cesar Vidal, Castro Antezana, Hardy Teresa, Pimenta, M Cristina, Bórquez, Annick, Luz, Paula M, Grinsztejn, Beatriz, Szwarcwald, Celia Landmann, Cáceres, Carlos F, Veloso, Valdilea G

“…HIV incidence estimation is critical for monitoring the HIV epidemic dynamics and the effectiveness of public health prevention interventions. We aimed to…”
Get full text

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study by Grinsztejn, Beatriz, Torres, Thiago Silva, Hoagland, Brenda, Jalil, Emilia Moreira, Moreira, Ronaldo Ismerio, O'Malley, Gabrielle, Shade, Starley B, Benedetti, Marcos R, Moreira, Julio, Simpson, Keila, Pimenta, Maria Cristina, Veloso, Valdiléa Gonçalves

“…Long-acting injectable cabotegravir (CAB-LA) for preexposure prophylaxis (PrEP) has proven efficacious in randomized controlled trials. Further research is…”
Get full text

Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter studyResearch in context by Thiago S. Torres, Sylvia L.M. Teixeira, Brenda Hoagland, Kelika A. Konda, Monica Derrico, Ronaldo I. Moreira, Juan V. Guanira, Marcos Benedetti, Sandro Nazer, Gino M. Calvo, Silver Vargas, Carlos Benites, Álisson Bigolin, José Boullosa Alonso Neto, Alessandro Farias, Marcos Vinícius Guimarães Lacerda, Daila Alena Raenck Silva, Leidijany Costa Paz, José Valdez Madruga, Hector Javier Salvatierra Flores, Ginjaylan Prada Boluarte, Cesar Vidal Osco Tamayo, Hardy Teresa Castro Antezana, M. Cristina Pimenta, Annick Bórquez, Paula M. Luz, Beatriz Grinsztejn, Celia Landmann Szwarcwald, Carlos F. Cáceres, Valdilea G. Veloso, Tania Kristic, Carla Rocha, Willian da Silva Santos, Ana Paula Lovreto Santana, Renato Lima, Carolina Souza, Talita Andrade Oliva, Mônica dos Santos Valões, Jennifer Olivetto, Gabriel Lima Mota, Aline Barnabé Cano, Roberta Trefiglio, Carolina Coutinho, Oliver Elorreaga, Ximena Gutierrez, Fernando Olivos, Damaris Caviedes, Daniella Adriazola, Eduardo Juárez, Gabriela Mariño, Jazmin Qquellon, Francesca Vasquez, Jean Pierre Jiron, Sonia Flores, Karen Campos, Maria Eguiluz

“…Background: HIV incidence estimation is critical for monitoring the HIV epidemic dynamics and the effectiveness of public health prevention interventions. We…”
Get full text

Efficacy and safety of TMC125 (etravirine) in treatment-experienced hiv-1-infected patients in DUET-1 : 24-week results from a randomised, double-blind, placebo-controlled trial. Commentary by HIRSCHEL, Bernard, PERNEGER, Thomas, PEETERS, Monika, VINGERHOETS, Johan, DE SMEDT, Goedele, LEOPOLD, Lorant, TREFIGLIO, Roberta, WOODFALL, Brian, LOZZARIN, Adriano, CAMPBELL, Thomas, CLOTET, Bonaventura, JOHNSON, Margaret, VALDEZ MADRUGA, José, KATLAMA, Christine, MOLL, Arend, TOWNER, William, TROTTIER, Benoit, PEETERS, Moniko, VINGERHOETS, Johan, DE SMEDT, Goedele, BAETEN, Benny, BEETS, Greet, SINHA, Rekha, CAHN, Pedro, WOODFALL, Brian, BERGER, Daniel, MCMURCHIE, Marilyn, SUTER, Fredy, BANHEGYI, Denes, RUXRUNGTHAM, Kiat, NOMS, Dorece, LEFEBVRE, Eric, DE BETHUNE, Marie-Pierre, TOMAKA, Frank, GRINSZTEJN, Beatriz, DE PAUW, Martine, VANGENEUGDEN, Tony, SPINOSA-GUZMAN, Sabrina, HAUBRICH, Richard, LALEZARI, Jacob, MILLS, Anthony, PIALOUX, Gilles, WILFEIN, Timothy

Get full text

Impact of regulatory assessment on clinical studies in Brazil by Russo, Luis Augusto Tavares, Eliaschewitz, Freddy Goldberg, Harada, Vitor, Trefiglio, Roberta Pereira, Picciotti, Raffaella, Machado, Paula Goulart Pinheiro, Kesselring, Gustavo Luiz Ferreira

“…Despite the recent expansion of clinical studies allocated to Brazil, the delay of local regulatory deadlines directly impacts their completion. This article…”
Get full text